Literature DB >> 10823847

Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent.

V Beringue1, K T Adjou, F Lamoury, T Maignien, J P Deslys, R Race, D Dormont.   

Abstract

The mode and the site of action of the major antiscrapie drugs have been studied by investigating their effects on the abnormal protease-resistant isoform of PrP (PrPres) and on its accumulation in mouse spleen. Day-by-day PrPres accumulation in the spleen and in other peripheral organs was first monitored to describe the early steps of scrapie pathogenesis. Three phases were identified: the detection of scrapie inoculum on the day of scrapie infection, a clearance phase, and then the peripheral accumulation of PrPres. In a second step, the effects of the polyene antibiotic MS-8209, the polyanion dextran sulfate 500 (DS500), and Congo red were assessed on these phases, after the drugs were coincubated with scrapie inoculum. Highly different mechanisms and sites of action were apparent. MS-8209 had a weak effect on the accumulation of PrPres in spleen, suggesting another site of intervention for this drug. DS500 delayed the beginning of the clearance phase but then blocked PrPres synthesis for a long period of time, probably because of its immunological effects on the spleen. Surprisingly, Congo red suppressed the clearance phase of scrapie inoculum and then increased transiently accumulation of PrPres in spleen. We showed in vitro that this effect was related to a direct enhancement of the protease resistance of PrPres by the drug.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823847      PMCID: PMC112027          DOI: 10.1128/jvi.74.12.5432-5440.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis.

Authors:  V Beringue; M Demoy; C I Lasmézas; B Gouritin; C Weingarten; J P Deslys; J P Andreux; P Couvreur; D Dormont
Journal:  J Pathol       Date:  2000-03       Impact factor: 7.996

2.  Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes.

Authors:  R H Kimberlin; C A Walker
Journal:  J Comp Pathol       Date:  1979-10       Impact factor: 1.311

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Action of dextran sulfate as a direct and general B cell mitogen.

Authors:  R Dörries; A Schimpl; E Wecker
Journal:  Eur J Immunol       Date:  1974-03       Impact factor: 5.532

5.  Measurement of the scrapie agent using an incubation time interval assay.

Authors:  S B Prusiner; S P Cochran; D F Groth; D E Downey; K A Bowman; H M Martinez
Journal:  Ann Neurol       Date:  1982-04       Impact factor: 10.422

6.  Stimulation of humoral antibody formation by polyanions. II. The influence of sulfate esters of polymers on the immune response in mice.

Authors:  T Diamantstein; B Wagner; I Beyse; M V Odenwald; G Schulz
Journal:  Eur J Immunol       Date:  1971-11       Impact factor: 5.532

7.  Effect of carrageenan on activity of the mononuclear phagocyte system in the mouse.

Authors:  E F Fowler; A W Thomson
Journal:  Br J Exp Pathol       Date:  1978-04

8.  Inhibiting scrapie neuroinvasion by polyene antibiotic treatment of SCID mice.

Authors:  V Beringue; C I Lasm Zas; K T Adjou; R Demaimay; F Lamoury; J P Deslys; M Seman; D Dormont
Journal:  J Gen Virol       Date:  1999-07       Impact factor: 3.891

9.  Dextran sulphate: an adjuvant for cell-mediated immune responses.

Authors:  R E McCarthy; L W Arnold; G F Babcock
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  15 in total

1.  Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Authors:  C Wong; L W Xiong; M Horiuchi; L Raymond; K Wehrly; B Chesebro; B Caughey
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.

Authors:  Sophie Halliez; Fabienne Reine; Laetitia Herzog; Emilie Jaumain; Stéphane Haïk; Human Rezaei; Jean-Luc Vilotte; Hubert Laude; Vincent Béringue
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

3.  Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.

Authors:  Tehila Mayer-Sonnenfeld; Dana Avrahami; Yael Friedman-Levi; Ruth Gabizon
Journal:  Cell Mol Neurobiol       Date:  2008-03-19       Impact factor: 5.046

4.  Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides.

Authors:  David A Kocisko; Andrew Vaillant; Kil Sun Lee; Kevin M Arnold; Nadine Bertholet; Richard E Race; Emily A Olsen; Jean-Marc Juteau; Byron Caughey
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

5.  Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.

Authors:  Sabrina Cronier; Vincent Beringue; Anne Bellon; Jean-Michel Peyrin; Hubert Laude
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

6.  Mechanistic insights into the cure of prion disease by novel antiprion compounds.

Authors:  Sarah Webb; Tamuna Lekishvili; Corinna Loeschner; Shane Sellarajah; Frances Prelli; Thomas Wisniewski; Ian H Gilbert; David R Brown
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

7.  Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis.

Authors:  Yael Friedman-Levi; Haim Ovadia; Romana Hoftberger; Ofira Einstein; Oded Abramsky; Herbert Budka; Ruth Gabizon
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

8.  Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.

Authors:  Yael Friedman-Levi; Romana Hoftberger; Herbert Budka; Tehila Mayer-Sonnenfeld; Oded Abramsky; Haim Ovadia; Ruth Gabizon
Journal:  J Neuroinflammation       Date:  2012-03-21       Impact factor: 8.322

9.  Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.

Authors:  David R Taylor; Isobel J Whitehouse; Nigel M Hooper
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

Review 10.  The role of prion strain diversity in the development of successful therapeutic treatments.

Authors:  Sara A M Holec; Alyssa J Block; Jason C Bartz
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-28       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.